Industry News – Page 4

RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System

Posted on September 21, 2020 by Denise Bell

Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the Mount Sinai Health System. This means that KidneyIntelX risk assessment of progressive decline in kidney function or kidney failure, including education support for treating clinicians, is now commercially available for patients with early stage diabetic kidney disease […]

2020 Bench to Bedside Participants Announced

Posted on September 18, 2020 by admin

Courtesy of University of Utah Academics & Research Postponed from its original in-person event last April, the annual medical innovation challenge has moved entirely online this year. Tuesday September 8, 2020 | Salt Lake City, UT Nearly five months after postponing the original in-person event in response to COVID-19, the 10th Annual Bench to Bedside competition […]

BioUtah Member Horizon Therapeutics Named to PEOPLE’s “50 Companies That Care” List

Posted on September 11, 2020 by Denise Bell

Horizon Therapeutics has been named to PEOPLE’s 2020 “50 Companies That Care” list. Partnering with Great Place to Work, PEOPLE identified the top U.S. companies that went above and beyond in responding to the pandemic.The list, focused on employers with 1,000 or more employees, will be featured in the Sept. 14, 2020 print issue of […]

Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases

Posted on September 11, 2020 by admin

By Chris Gibson, PhD via Recursion – Drug discovery partnership and equity investment led by Leaps by Bayer in Series D financing round – Digitally-powered drug discovery to address fibrotic diseases with previously undiscovered mechanisms and to deliver novel therapies to patients faster Berlin, Germany and Salt Lake City, USA, September 9, 2020 – Bayer and […]

BioUtah and Utah Biotech/Biopharma Companies Raise Concerns About Impact of Trump’s “Most-Favored-Nation” Drug Pricing Order on Innovation

Posted on August 19, 2020 by admin

BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives urging opposition to the President’s directive to impose “most-favored nation” pricing on Medicare Part B drugs. The letter notes that if the executive order moves forward, investment dollars for Utah’s smaller drug discovery companies could dry up […]

BioUtah Statement on Launch of Altitude Lab, Largest Life Sciences Incubator in Utah

Posted on August 12, 2020 by admin

Recursion and University of Utah found incubator to propel new generation of life sciences in the region August 12, 2020 04:18 PM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–BioUtah President and CEO, Kelvyn Cullimore, issued the following statement following the announcement of the opening of Altitude Lab. “This is truly a life sciences milestone in […]

Recap of Stock Market Update with Monica DiCenso of JP Morgan

Posted on July 31, 2020 by admin

After leaving quite an impression to the attendees of the 2020 Entrepreneur and Investor Summit, we brought Monica DiCenso, managing director and head of Global Investment Opportunities Group at J.P. Morgan, back for a mid-year update on the stock market. In the webinar, Ms. Dicenso provided important insight into the rebound of the economy since […]

Initial Data for Moderna COVID-19 Vaccine Shows Promise

Posted on July 17, 2020 by Denise Bell

On Tuesday, Moderna announced promising results from the Phase 1 study of its vaccine candidate, called mRNA-1273. The study, published in The New England Journal of Medicine showed that all 45 volunteers who received two vaccine doses developed immune responses that were stronger than in patients who have recovered from COVID-19. “These positive Phase 1 […]

BioFire Respiratory Panel with COVID Target Scores CE Mark

Posted on July 17, 2020 by Denise Bell

BioMerieux announced that Utah-based BioFire’s Respiratory Panel 2.1 plus, which tests for SARS-CoV-2 and 23 pathogens encompassing 19 viruses, and four bacteria that cause the most frequent respiratory tract infections, has received CE marking. “It’s exciting to see the advances that BioFire is making in COVID-19 and infectious disease diagnostics,” said Kelvyn Cullimore, president and […]

Pfizer, BioNTech Get FDA Fast Track Status for COVID-19 Vaccines

Posted on July 17, 2020 by Denise Bell

U.S. Pfizer and Germany’s BioNTech announced Monday that they have received Fast Track designation from the FDA for two COVID-19 vaccine candidates – BNT162b1 and BNT162b2 – part of the companies’ “Project Lightspeed” program. The designation was issued based on promising preliminary data from Phase 1/2 clinical studies. The FDA’s Fast Track designation is intended […]